http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040014813-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_424a307dca52700a31b69940917f542f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_944d4fd503614f12576bde0d96971a8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8a3bb71cfa6445c719dc4eaa66d8fce |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36 |
| filingDate | 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a5dddc441a5e661ac4aad101021e1ee http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5a8c832550f5b4fb6bed23643c4275e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83d5ca91a8b10544d712f2e3fff33dd1 |
| publicationDate | 2004-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040014813-A |
| titleOfInvention | Pharmaceutical compositions for protection and remidy of Dirofilaria immitis infection comprising arsenic oxide effective components |
| abstract | The present invention provides As 4 O 6 as an active ingredient for the prevention and treatment of filamentous worms, which is an infection of mammals and humans, including dogs, cats, ferrets, foxes, wolves, sea lions and horses. The present invention relates to a pharmaceutical composition for preventing and treating filamentous worms, and more particularly to mammals and humans, including dogs, cats, ferrets, foxes, wolves, sea lions and horses infected with Dirophyllaria imitis. It relates to a pharmaceutical composition for preventing and treating filamentous worms by administering a pharmaceutical composition containing 4 O 6 as an active ingredient.n n n In another aspect, the present invention is administered to a mammal, including dogs, cats, ferrets, foxes, wolves, sea lions, horses, and humans infected with parasites to the pharmaceutical composition comprising As 4 O 6 as an active ingredient from the mammals and humans It relates to a pharmaceutical composition for preventing and treating parasites for preventing and treating various parasites generated. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3110394-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10525079-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011145105-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018093215-A1 |
| priorityDate | 2002-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.